TITLE: Medicare Supplemental Insurance

CIS-NO: 2002-H781-16  
SOURCE: Committee on Ways and Means. House  
DOC-TYPE: Hearing Retrieve the full text of testimony  
DATE: Mar. 14, 2002  
LENGTH: iii+55 p.  
CONG-SESS: 107-2  
ITEM-NO: 1028-A; 1028-B  
SUDOC: Y4.W36:107-60  
 
GPO-STOCK-NO: 552-070-28267-0.

SUMMARY:
Committee Serial No. 107-60. Hearing before the Subcom on Health to examine Administration proposal to reform the Medicare supplemental insurance program, known as Medigap (Subcom advisories, p. 2-4).
 
Supplementary material (p. 50-55) includes a witness's written replies to Subcom questions and a submitted statement.

CONTENT-NOTATION: Medicare supplemental insurance program revision

DESCRIPTORS:  
   SUBCOM ON HEALTH, WAYS AND MEANS. HOUSE;  MEDICARE; MEDICAL REGULATION

02-H781-16 TESTIMONY NO: 1     Mar. 14, 2002 p. 8-51
 
WITNESSES (and witness notations):
   JINDAL, BOBBY P. (Assistant Secretary, Planning and Evaluation, HHS)
   SCANLON, WILLIAM J. (Director, Health Care Issues, GAO)
   YOUNG, DONALD A. (Dr.) (President, Health Insurance Association)
   WEISS, JENNIFER (Director, Policy, Medical Rights Center)
 
STATEMENTS AND DISCUSSION:
   Overview of Administration proposals for Medigap reform; deficiencies of current Medicare and Medigap policies, including high premiums for prescription drugs; need for affordable prescription drug coverage in Medigap reform; support for Administration proposal to improve Medigap coverage.
 
CONTENT NOTATION:
   Medicare supplemental insurance program revision
 
TESTIMONY DESCRIPTORS:
   HEALTH INSURANCE ASSOCIATION; MEDICAL RIGHTS CENTER; DEPARTMENT OF HEALTH AND HUMAN SERVICES; GENERAL ACCOUNTING OFFICE; DRUGS

LOAD-DATE: February 3, 2003